Skip to content

The effect of an antibody (Ab) against human IL-6 in the transplant model of psoriasis.

The effect of an antibody (Ab) against human IL-6 in the transplant model of psoriasis. - The effect of an Ab against IL-6 in the transplant model of psoriasis.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34138
Enrollment
11
Registered
2010-08-09
Start date
2010-09-22
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

None listed

Sponsors

Argen-X
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Mild to moderate psoriasis vulgaris

Exclusion criteria

Exclusion criteria: Volunteers can not be taking drugs systemically, including immune-modifiers for other diseases. Volunteers cannot be be undergoing UV/light therapy Volunteers should not show Kobner phenomenon at wound sites.

Design outcomes

Primary

MeasureTime frame
NVT

Secondary

MeasureTime frame
NVT

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)